PENTAX Medical Appoints Global Chief Clinical Officer

PENTAX Medical, a division of HOYA Corporation, has appointed Dr. Hudson Garrett as global chief clinical officer. In this executive role, Garrett is responsible for leading all PENTAX Medical clinical related activities globally.
 
PENTAX Medical established the new role to accelerate its focus on delivering clinically relevant products to improve quality and standard of patient care. Garrett’s expertise and experiences in infection control in various medical institutions will enforce its commitment to minimize risk of infection and cross contamination, executives said. It will also further develop the scientific community by investing in professional education to raise the bar of patient care.
 
“Hudson joins PENTAX Medical with valuable expertise gained from various segments of the medical field on the vender and provider side”, said David Woods, global chief medical officer of PENTAX Medical. “He has the credentials and expertise to oversee PENTAX Medical’s clinical activities by working with our customers, industry partners and internal team members to develop and deliver high quality products cost effectively with attention to provider and patient satisfaction.”

Garrett has a bachelor of science degree in biology/chemistry and nursing, dual masters degrees in nursing and public health, a post-masters certificate as a family nurse practitioner, a post-masters certificate in infection prevention and control, and a Ph.D. in healthcare administration and policy. He is a graduate of the Johns Hopkins Fellowship in Infection Control and Hospital Epidemiology, and was honored as a Who’s Who in Infection Control Today Magazine in 2013.
 
“I am committed to make the best use of my clinical background in infection prevention, control and clinical affairs to position PENTAX Medical as a thought leader in medical device hygiene, evidence-based clinical education, and clinical research,” Garrett said. “I am committed to ensuring we clearly demonstrate the PENTAX Medical ethos of offering clinically advanced evidence-based products.”
 
PENTAX Medical is a division of Hoya Group, providing endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a global focus and presence with R&D, regional sales, service, and in-country facilities worldwide.